BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 31869252)

  • 1. PIN1 Attenuation Improves Midface Hypoplasia in a Mouse Model of Apert Syndrome.
    Kim B; Shin H; Kim W; Kim H; Cho Y; Yoon H; Baek J; Woo K; Lee Y; Ryoo H
    J Dent Res; 2020 Feb; 99(2):223-232. PubMed ID: 31869252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PIN1 is a new therapeutic target of craniosynostosis.
    Shin HR; Bae HS; Kim BS; Yoon HI; Cho YD; Kim WJ; Choi KY; Lee YS; Woo KM; Baek JH; Ryoo HM
    Hum Mol Genet; 2018 Nov; 27(22):3827-3839. PubMed ID: 30007339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synchondrosis fusion contributes to the progression of postnatal craniofacial dysmorphology in syndromic craniosynostosis.
    Hoshino Y; Takechi M; Moazen M; Steacy M; Koyabu D; Furutera T; Ninomiya Y; Nuri T; Pauws E; Iseki S
    J Anat; 2023 Mar; 242(3):387-401. PubMed ID: 36394990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facial suture synostosis of newborn Fgfr1(P250R/+) and Fgfr2(S252W/+) mouse models of Pfeiffer and Apert syndromes.
    Purushothaman R; Cox TC; Maga AM; Cunningham ML
    Birth Defects Res A Clin Mol Teratol; 2011 Jul; 91(7):603-9. PubMed ID: 21538817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Midface and upper airway dysgenesis in FGFR2-related craniosynostosis involves multiple tissue-specific and cell cycle effects.
    Holmes G; O'Rourke C; Motch Perrine SM; Lu N; van Bakel H; Richtsmeier JT; Jabs EW
    Development; 2018 Oct; 145(19):. PubMed ID: 30228104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Septal chondrocyte hypertrophy contributes to midface deformity in a mouse model of Apert syndrome.
    Kim BS; Shin HR; Kim HJ; Yoon H; Cho YD; Choi KY; Choi JY; Kim WJ; Ryoo HM
    Sci Rep; 2021 Apr; 11(1):7979. PubMed ID: 33846505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond the closed suture in apert syndrome mouse models: evidence of primary effects of FGFR2 signaling on facial shape at birth.
    Martínez-Abadías N; Percival C; Aldridge K; Hill CA; Ryan T; Sirivunnabood S; Wang Y; Jabs EW; Richtsmeier JT
    Dev Dyn; 2010 Nov; 239(11):3058-71. PubMed ID: 20842696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Pro253Arg mutation in fibroblast growth factor receptor 2 (Fgfr2) causes skeleton malformation mimicking human Apert syndrome by affecting both chondrogenesis and osteogenesis.
    Yin L; Du X; Li C; Xu X; Chen Z; Su N; Zhao L; Qi H; Li F; Xue J; Yang J; Jin M; Deng C; Chen L
    Bone; 2008 Apr; 42(4):631-43. PubMed ID: 18242159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further analysis of the Crouzon mouse: effects of the FGFR2(C342Y) mutation are cranial bone-dependent.
    Liu J; Nam HK; Wang E; Hatch NE
    Calcif Tissue Int; 2013 May; 92(5):451-66. PubMed ID: 23358860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of p38 MAPK pathway in the skull abnormalities of Apert syndrome Fgfr2(+P253R) mice.
    Wang Y; Sun M; Uhlhorn VL; Zhou X; Peter I; Martinez-Abadias N; Hill CA; Percival CJ; Richtsmeier JT; Huso DL; Jabs EW
    BMC Dev Biol; 2010 Feb; 10():22. PubMed ID: 20175913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphological comparison of the craniofacial phenotypes of mouse models expressing the Apert FGFR2 S252W mutation in neural crest- or mesoderm-derived tissues.
    Heuzé Y; Singh N; Basilico C; Jabs EW; Holmes G; Richtsmeier JT
    Bone; 2014 Jun; 63():101-9. PubMed ID: 24632501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesodermal expression of Fgfr2S252W is necessary and sufficient to induce craniosynostosis in a mouse model of Apert syndrome.
    Holmes G; Basilico C
    Dev Biol; 2012 Aug; 368(2):283-93. PubMed ID: 22664175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Craniofacial divergence by distinct prenatal growth patterns in Fgfr2 mutant mice.
    Motch Perrine SM; Cole TM; Martínez-Abadías N; Aldridge K; Jabs EW; Richtsmeier JT
    BMC Dev Biol; 2014 Feb; 14():8. PubMed ID: 24580805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The study of abnormal bone development in the Apert syndrome Fgfr2+/S252W mouse using a 3D hydrogel culture model.
    Yang F; Wang Y; Zhang Z; Hsu B; Jabs EW; Elisseeff JH
    Bone; 2008 Jul; 43(1):55-63. PubMed ID: 18407821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrantly activated Wnt/β-catenin pathway co-receptors LRP5 and LRP6 regulate osteoblast differentiation in the developing coronal sutures of an Apert syndrome (Fgfr2
    Min Swe NM; Kobayashi Y; Kamimoto H; Moriyama K
    Dev Dyn; 2021 Mar; 250(3):465-476. PubMed ID: 32822074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facial skeleton dysmorphology in syndromic craniosynostosis: differences between FGFR2 and no-FGFR2-related syndromes and relationship with skull base and facial sutural patterns.
    Calandrelli R; Pilato F; Massimi L; D'Apolito G; Colosimo C
    Childs Nerv Syst; 2023 Nov; 39(11):3235-3247. PubMed ID: 37195419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deformed Skull Morphology Is Caused by the Combined Effects of the Maldevelopment of Calvarias, Cranial Base and Brain in FGFR2-P253R Mice Mimicking Human Apert Syndrome.
    Luo F; Xie Y; Xu W; Huang J; Zhou S; Wang Z; Luo X; Liu M; Chen L; Du X
    Int J Biol Sci; 2017; 13(1):32-45. PubMed ID: 28123344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble form of FGFR2 with S252W partially prevents craniosynostosis of the apert mouse model.
    Morita J; Nakamura M; Kobayashi Y; Deng CX; Funato N; Moriyama K
    Dev Dyn; 2014 Apr; 243(4):560-7. PubMed ID: 24259495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The craniofacial phenotype of the Crouzon mouse: analysis of a model for syndromic craniosynostosis using three-dimensional MicroCT.
    Perlyn CA; DeLeon VB; Babbs C; Govier D; Burell L; Darvann T; Kreiborg S; Morriss-Kay G
    Cleft Palate Craniofac J; 2006 Nov; 43(6):740-8. PubMed ID: 17105336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early mandibular morphological differences in patients with FGFR2 and FGFR3-related syndromic craniosynostoses: A 3D comparative study.
    Morice A; Cornette R; Giudice A; Collet C; Paternoster G; Arnaud É; Galliani E; Picard A; Legeai-Mallet L; Khonsari RH
    Bone; 2020 Dec; 141():115600. PubMed ID: 32822871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.